Browsing by Author Brown, Christopher

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 38  next >
Issue DateTitleAuthor(s)Citation
2012Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialBrown, Christopher; De Rauglaudre, G; Elit, Laurie; Ferrero, A.; Gladieff, Laurence; Helland, H; Lorusso, D; Mahner, S; Pujade-Lauraine, Eric; Reed, N; Reinthaller, A; Siena, Salvatore; Vasey, P; NH&MRC Clinical Trials CentreCarboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial, Annals of Oncology, vol.23, 5, 2012,pp 1185-1189
2015Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trialBrown, Christopher; Bessette, Paul; Cretin, Jacques; Dell'Anna, Tiziana; du Bois, Andreas; et al, Various; Havsteen, Hanne; Lorusso, Domenica; Mahner, S; Meier, W; Zeimet, Alain; NH&MRC Clinical Trials CentreCarboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial, European Journal of Cancer, vol.51, 3, 2015,pp 352-358
2011Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancerBrown, Christopher; Gebski, Val; Gurney, Howard; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Bacon, M; Donadello, Nicoletta; Friedlander, Michael; Maenpaa, J; Meier, W; Petru, E; Pujade-Lauraine, Eric; Reed, N; Sorio, R; Tulunay, G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCarboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer, British Journal of Cancer, vol.105, 3, 2011,pp 360-365
2017Changes in maternal abdominal subcutaneous fat layers using ultrasound: A longitudinal studyBenzie, Ronald; Brown, Christopher; Kennedy, Narelle; Nanan, Ralph; Quinton, Ann; Peek, M; Nepean Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Medical Radiation Sciences; Nepean Clinical School: Paediatrics & Child Health; Nepean Clinical School: Obstetrics & GynaecologyChanges in maternal abdominal subcutaneous fat layers using ultrasound: A longitudinal study, Obesity Research & Clinical Practice, vol.11, 6, 2017,pp 655-664
2011Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.Brown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Delva, Remy; Donadello, Nicoletta; Friedlander, Michael L.; Georgoulopoulos, Alexander; Mirza, Mansoor Raza; Pignata, Sandro; Pujade-Lauraine, Eric; Schmalfeldt, Barbara; Southier, Philippe; Vergote, Ignace; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer., Journal of the National Cancer Institute, vol.103, 17, 2011,pp 1338-1342
2010Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasBrown, Christopher; Gainford, Mary; Gebski, Val; Miller, Danielle; Abdi, Ehtesham A; Ackland, Stephen P.; Goldstein, D; Jefford, Michael; Selva-Nayagam, Sid; Shannon, Jenny; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas, Cancer Chemotherapy and Pharmacology, vol.0, 0,pp 1-7
2012The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerBrown, Christopher; Gebski, Val; Horvath, Lisa; Hruby, George; Ackland, Stephen P.; Borg, M; Carroll, Susan; Cummins, Michelle M; et al, Various; Goldstein, David; Selva-Nayagam, Sid; Shapiro, Jeremy; Spry, Nigel.A.; van Hazel, Guy; Wratten, C.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: MedicineThe GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer, British Journal of Cancer, vol.106, 1, 2012,pp 61-69
2013Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-AnalysisBrown, Christopher; Gebski, Val; Lee, Chee; Chu, Da Tong; et al, Various; Gralla, Richard J; Hirsh, V; Ho, James Chung-Man; Osorio Sanchez, Jemela Anne; Tan, E; Thongprasert, Sumitra; Tsai, Chun-Ming; Vu, VuVan; Zaatar, Adel; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreImpact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis, National Cancer Institute. Journal, vol.105, 9, 2013,pp 595-605
2017Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort studyBrown, Christopher; Pearson, Sallie-Anne; Haas, Marion; Haywood, Philip; Pearce, Alison; Viney, Rosalie; Ward, Robyn; NH&MRC Clinical Trials Centre; PharmacyIncidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study, PloS One, vol.12, 10, 2017,pp 1-12
2013Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysisBrown, Christopher; Chalasani, Venu; Grimison, Peter; Houghton, Baerin; Patel, Manish; Stockler, Martin; Davis, Ian; Hayne, Dickon; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Surgery; School of Public Health: NH&MRC Clinical Trials CentreIntravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis, BJU International, vol.111, 6, 2013,pp 977-983
2012Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 DiabetesBarter, Philip; Brown, Christopher; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Sullivan, David; Xu, Aimin; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Molecular BioscienceLong-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes, Journal of Clinical Endocrinology and Metabolism, vol.97, 12, 2012,pp 4701-4708
2011Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?Blinman, Prunella; Brown, Christopher; Duric, Vlatka; Stockler, Martin; Fong, K; McLachlan, Sue-Anne; Millward, Michael; Nowak, Anna K.; Wright, Gavin; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?, Lung cancer, vol.72, 2, 2011,pp 213-218
2013Markers of systemic inflammation predict survival in patients with advanced renal cell cancerBrown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); de Souza, Paul; Fox, P; Hudson, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMarkers of systemic inflammation predict survival in patients with advanced renal cell cancer, British Journal of Cancer, vol.109, 1, 2013,pp 147-153
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88
2018The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorderBrakoulias, Vlasios (Bill); Brown, Christopher; Starcevic, Vladan; Viswasam, Kirupamani (Mani); Hannan, Anthony; Milicevic, Denise; Nepean Clinical School: Psychiatry; NH&MRC Clinical Trials Centre; Nepean Clinical School: Medicine; Nepean Clinical School: MedicineThe Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder, International Journal of Psychiatry in Clinical Practice, vol.22, 2, 2018,pp 84-88